A detailed history of Prospect Financial Group LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Prospect Financial Group LLC holds 562 shares of LLY stock, worth $574,195. This represents 0.42% of its overall portfolio holdings.

Number of Shares
562
Previous 537 4.66%
Holding current value
$574,195
Previous $419 Million 2.44%
% of portfolio
0.42%
Previous 0.44%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

BUY
$625.65 - $812.69 $15,641 - $20,317
25 Added 4.66%
562 $429 Million
Q2 2025

Aug 07, 2025

BUY
$713.71 - $898.95 $43,536 - $54,835
61 Added 12.82%
537 $419 Million
Q1 2025

May 06, 2025

BUY
$725.72 - $929.72 $18,143 - $23,243
25 Added 5.54%
476 $393 Million
Q4 2024

Feb 11, 2025

BUY
$727.2 - $932.06 $327,967 - $420,359
451 New
451 $348 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Prospect Financial Group LLC Portfolio

Follow Prospect Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospect Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prospect Financial Group LLC with notifications on news.